×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 7 - Panel Discussion
Session Chair(s)
Paul D. Huckle
Chief Regulatory Officer and Senior Vice President, Global Regulatory Affairs
GlaxoSmithKline, United States
This session will consist of an open discussion of critical topics. The audience will have the opportunity to ask leading industry and regulatory experts questions on benefit-risk assessment.
Speaker(s)
Panelists
Robyn R. Lim, PhD
Health Canada, Canada
Senior Science Advisor, Health Products and Food Branch
Bruno Flamion, MD, PhD
Idorsia Pharmaceuticals Ltd, Switzerland
VP, Head Strategic Development
K. Kimberly McCleary
The Kith Collective, LLC, United States
Founder and Chief Executive Officer
Andrea Tan
FDA, United States
Operations Research Analyst, OSP, CDER
Robert Ball, MD, MPH, MSc
FDA, United States
Deputy Director, Office of Surveillance and Epidemiology, CDER
Have an account?